Berberine With Metformin, Inositol or Milk Thistle: What the Evidence Says About Stacking

Why stacking is a different question from taking berberine alone

A supplement “stack” means taking two or more products together. Each product has its own evidence, and the combination has its own unknowns. Most claims about stacking are inferences: because compound A acts on pathway X and compound B acts on pathway Y, people expect them to add up. That reasoning can be sound as a hypothesis, but it is not evidence that the pair works or that it is safe. The few direct studies of a pair are what count, and for berberine they are scarce.

For readers, the practical consequence is that the most important question is not “which stack works best” but “what else am I taking, and who knows about it?” A pharmacist can check a pair against your full medicines list, which a general article cannot do.

Berberine and metformin

What the NHS says

The NHS medicines page for metformin states that there is not enough information to say that complementary medicines and herbal remedies are safe to take with metformin, adds that they are not tested in the same way as prescription medicines and are generally not tested for their effects on other medicines, and asks people to tell their doctor or pharmacist about any herbal remedies, vitamins or supplements they take ^[1]. That is general advice about supplements, not a finding about berberine specifically, but it frames the question correctly.

Laboratory and rat evidence on the transporters

Metformin enters cells through carrier proteins called organic cation transporters (OCT1 and OCT2), a little like a turnstile that lets the drug through. A study using human kidney-derived cells engineered to produce these transporters found that berberine reduced metformin uptake in a concentration-dependent way, with half-maximal inhibition at about 7.28 micromolar for OCT1 and 11.3 micromolar for OCT2 ^[2]. In rats given a single intravenous dose of metformin together with berberine, metformin’s starting plasma concentration and total exposure rose, and its clearance and volume of distribution fell ^[2]. The authors concluded that berberine has meaningful potential to interact with metformin, at least in rats ^[2].

That is a preclinical finding. Cells in a dish and a single intravenous dose in rats do not tell us what happens when a person swallows both products, because berberine is poorly absorbed and blood levels in people are low. We did not find a human study of berberine’s effect on metformin levels that we could open, so the interaction is a plausible mechanism, not a demonstrated outcome in people.

What the clinical trials show

In the 2008 pilot trial, a second part added 500 mg of berberine three times daily to existing treatment in 48 adults with poorly controlled type 2 diabetes, and HbA1c fell from 8.1% to 7.3% ^[4]. It had no placebo group. A 2022 meta-analysis of 37 randomised trials pooled berberine used alone or alongside other glucose-lowering treatment, and found lower fasting glucose and HbA1c with berberine ^[5]. The same review found that total adverse events were not higher with berberine, but hypoglycaemia was reported in only two of nine trials that assessed it, and the authors rated the certainty of that outcome as very low ^[5].

Two things follow. First, additive glucose lowering is what the trials were looking for, so it is the effect you should expect rather than avoid. Second, the trials were not designed to tell an individual taking metformin whether their dose should change or whether combining the two is safe. That judgement belongs to a clinician who knows your kidney function, other medicines and glucose readings, and it should not be made by cutting or changing metformin yourself.

Berberine and other medicines

A two-week crossover study in healthy men taking 300 mg of berberine three times daily found reduced activity of the liver enzymes CYP2D6, CYP2C9 and CYP3A4, with exposure to the CYP3A4 test drug midazolam about 40% higher, and no significant change in CYP2C19 or CYP1A2 ^[3]. EFSA’s 2026 draft assessment also reports possible CYP3A4 inhibition ^[10]. These are changes in enzyme activity, not proven clinical harm, and their importance depends on the medicine. That is why a pharmacist check matters even when a supplement looks harmless.

Berberine and myo-inositol for PCOS

Inositol is a sugar-like compound sold as a food supplement, and myo-inositol is the form most often discussed for PCOS. A 2024 systematic review prepared for the international PCOS guideline update analysed 30 trials with 2,230 participants. It found that inositol may benefit some metabolic measures, that a related form, D-chiro-inositol, may benefit ovulation, that inositol may have no effect on other outcomes, and that metformin likely makes no difference to reproductive outcomes compared with inositol, while metformin may improve waist-hip ratio and hirsutism (excess hair growth) ^[6]. Myo-inositol likely caused fewer gut side effects than metformin, typically mild and short-lived ^[6]. The authors’ overall conclusion was that the evidence for inositol in PCOS is limited and inconclusive ^[6].

None of that addresses berberine. We did not find a trial of berberine and myo-inositol together that we could review in full, and we found no documented interaction between the two in the sources we checked. So “can you take them on the same day?” has no evidence-based yes or no. The idea behind the pairing, that the two work through different routes and might complement each other, is a hypothesis. If you are being treated for PCOS, or are trying to conceive, tell your GP or specialist about both supplements, because the Food Standards Agency advises checking with a healthcare professional before using supplements if you are pregnant or breastfeeding ^[11].

Berberine and milk thistle (silymarin)

Milk thistle extract, standardised to silymarin, is sold on its own and in fixed combinations with berberine. The one study of such a combination that we found was a small study in 69 adults with type 2 diabetes who were already taking diet measures and glucose-lowering medicines. One group took a berberine extract (1,000 mg of berberine a day), and the other took the same dose plus 210 mg of silymarin a day. Both groups improved fasting glucose, cholesterol, triglycerides and liver enzymes to a similar degree, and HbA1c fell more with the combination ^[7]. We only reviewed the abstract, which does not state whether allocation was random, how long treatment lasted or how large the differences were, and it gives no side-effect data ^[7]. It is a preliminary finding at best.

Why do people take milk thistle with berberine? One proposed explanation is that silymarin blocks the P-glycoprotein pump that pushes berberine back out of the gut, so that more berberine reaches the blood. We found no human absorption study showing that, and we cannot confirm it. Another reason given for the pairing is liver support. Neither reason is supported by trials we could review, so treat the pairing as a marketing convention rather than an established stack.

CoQ10, cinnamon, chromium and other add-ons

Our searches found no trial that combined berberine with coenzyme Q10, cinnamon or chromium, and no berberine-specific evidence that any of them prevents muscle fatigue or improves insulin resistance when added. Their separate evidence bases, if any, do not transfer to berberine. Our search was not exhaustive, and absence of a study we found is not proof that none exists, but it does mean such stack claims should be read as speculation until a study is cited.

Signs of low blood sugar when combining glucose-lowering products

Low blood sugar mainly affects people with diabetes who take insulin or some other diabetes medicines, and the NHS says it is rare in people without diabetes ^[8]. Drinkaware lists dizziness, hunger, sweating, trembling, trouble concentrating and mood changes among the most common signs, and the NHS advises calling 999 for someone having a severe hypo ^[9]. If you take diabetes medicines and notice these symptoms after starting berberine or adding another glucose-lowering product, contact your GP, pharmacist or diabetes team rather than adjusting doses yourself. The NHS also advises seeing a GP if you have diabetes and get low blood sugar at night ^[8].

Dosage context

There is no licensed UK dose of berberine, because supplements are regulated as food, and the Food Standards Agency advises following the label and not exceeding the recommended dose ^[11]. The study doses above were 500 mg three times daily (2008 pilot) ^[4] and 1,000 mg of berberine a day with or without 210 mg of silymarin a day ^[7]. These are research regimens, not recommendations, and none were tested against the other products discussed here. We did not extract inositol doses from the review, so follow the product label and your clinician’s advice.

Frequently asked questions

Editorial summary

Stacking berberine with other products rests mostly on reasoning, not on studies of the pair. For metformin there is a plausible laboratory mechanism, human enzyme data and an NHS statement that herbal remedies are not shown to be safe alongside it, but no human study of the combination’s safety in individuals. For inositol, the evidence for inositol alone is limited and no combined trial was found. For milk thistle, there is one preliminary abstract. For CoQ10, cinnamon and chromium, we found nothing.

For readers, the sensible approach is to tell your GP or pharmacist about every product you take, especially if you use diabetes medicines or have PCOS, and to treat stack claims as hypotheses until a trial is cited. Combination trials with safety and glucose outcomes would change this picture. Evidence reviewed on 5 November 2026.

References

1. NHS. Metformin: cautions with other medicines and herbal supplements. NHS medicines page
2. Organic cation transporter-mediated drug-drug interaction potential between berberine and metformin. (Cell and rat study.) PubMed record
3. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. DOI 10.1007/s00228-011-1108-2. Springer record
4. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712–717. PubMed record
5. Xie W, Su F, Wang G, et al. Glucose-lowering effect of berberine on type 2 diabetes: a systematic review and meta-analysis. Front Pharmacol. 2022;13:1015045. Full text
6. Fitz V, Graca S, Mahalingaiah S, et al. Inositol for polycystic ovary syndrome: a systematic review and meta-analysis to inform the 2023 update of the international evidence-based PCOS guidelines. J Clin Endocrinol Metab. 2024;109(6):1630–1655. doi:10.1210/clinem/dgad762. Monash University record (abstract)
7. Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. Clin Pharmacol Adv Appl. 2013. (Abstract only reviewed.) Dove Medical Press page
8. NHS. Low blood sugar (hypoglycaemia). NHS Health A to Z
9. Drinkaware. Alcohol and diabetes. Drinkaware page
10. European Food Safety Authority. EFSA’s draft opinion on the safety of plant preparations containing berberine: stakeholder webinar slides, 22 April 2026. EFSA slides (PDF)
11. Food Standards Agency. Food supplements guidance (consumers). GOV.UK, published 25 June 2026. GOV.UK guidance